- Home
- RIGL vs HDSN Comparison
RIGL vs HDSN Comparison
Compare RIGL & HDSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- HDSN
- Stock Information
- Founded
- RIGL 1996
- HDSN 1991
- Country
- RIGL United States
- HDSN United States
- Employees
- RIGL N/A
- HDSN N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- HDSN Industrial Specialties
- Sector
- RIGL Health Care
- HDSN Consumer Discretionary
- Exchange
- RIGL Nasdaq
- HDSN Nasdaq
- Market Cap
- RIGL 298.0M
- HDSN 266.4M
- IPO Year
- RIGL 2000
- HDSN 1994
- Fundamental
- Price
- RIGL $17.28
- HDSN $5.27
- Analyst Decision
- RIGL Buy
- HDSN Hold
- Analyst Count
- RIGL 5
- HDSN 4
- Target Price
- RIGL $36.80
- HDSN $6.88
- AVG Volume (30 Days)
- RIGL 222.1K
- HDSN 432.8K
- Earning Date
- RIGL 05-06-2025
- HDSN 04-30-2025
- Dividend Yield
- RIGL N/A
- HDSN N/A
- EPS Growth
- RIGL N/A
- HDSN N/A
- EPS
- RIGL 0.99
- HDSN 0.52
- Revenue
- RIGL $179,278,000.00
- HDSN $237,118,000.00
- Revenue This Year
- RIGL $12.53
- HDSN N/A
- Revenue Next Year
- RIGL $15.68
- HDSN $10.35
- P/E Ratio
- RIGL $17.36
- HDSN $10.01
- Revenue Growth
- RIGL 54.71
- HDSN N/A
- 52 Week Low
- RIGL $7.48
- HDSN $5.11
- 52 Week High
- RIGL $29.82
- HDSN $10.84
- Technical
- Relative Strength Index (RSI)
- RIGL 44.84
- HDSN 37.56
- Support Level
- RIGL $16.05
- HDSN $5.20
- Resistance Level
- RIGL $17.52
- HDSN $5.88
- Average True Range (ATR)
- RIGL 1.26
- HDSN 0.30
- MACD
- RIGL 0.10
- HDSN -0.05
- Stochastic Oscillator
- RIGL 63.57
- HDSN 14.09
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About HDSN Hudson Technologies Inc.
Hudson Technologies Inc is an American industrial products manufacturer. It develops products which are mainly used in commercial air conditioning, industrial processing, and refrigeration systems. The company products include refrigerant and industrial gases, refrigerant management services and RefrigerantSide services, which consist of system decontamination. These are performed at customer's site using its Zugibeast system, which is a fast and portable system and allows the R-Side services team to accelerate critical services while saving customers time, money and aggravation. The company also owns a web-based real-time monitoring service which is used in the facility's refrigeration systems and other energy systems.